711TH HPW/usafsam/PH luminex reagents BPA

Ended Awarded Last action

Contract number
FA239625FB246
Awardee
Awarding agency
Obligated
$154,970

Award facts

Contract value 100% obligated
$154,970.00 Current and potential, with all options
Completion date
Current and potential, with all options
Contracting staff
Funding agency
Defense Health Agency Department of Defense
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Austin, TX 78727, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Health Agency has awarded a $154,970 firm fixed-price blanket purchase agreement call to Luminex Corp for Luminex reagents in support of the 711th Human Performance Wing (HPW) at the United States Air Force School of Aerospace Medicine (USAFSAM). The award, issued on September 17, 2025, with an ultimate completion date of the same day, represents a call against Luminex Corp's broader $5.76 million blanket purchase agreement with the Air Force for diagnostic reagents. This contract utilizes the GSA Schedule for In Vitro Diagnostics, Reagents, and Test Kits and carries no set-aside designation, indicating open competition. The place of performance is Austin, Texas, where Luminex Corp maintains its headquarters.

Luminex Corp, a foreign-owned manufacturer of advanced biological testing technologies, has an established track record supplying sophisticated diagnostic solutions across multiple federal agencies, including the Centers for Disease Control and Prevention, Department of Veterans Affairs, Department of Agriculture, and National Institutes of Health. The company specializes in multiplex diagnostic systems, assay kits, and laboratory equipment. This contract enables the Air Force's Human Performance Wing to efficiently procure specialized diagnostic reagents through an established contracting mechanism, supporting the agency's mission-critical testing and research capabilities in aerospace medicine and operational health initiatives.

Quick answers

Who was awarded contract FA239625FB246?

FA239625FB246 was awarded to Luminex Corp by Air Force (Department of Defense) on September 17, 2025.

How much is contract FA239625FB246 worth?

The government has obligated $154,970 on FA239625FB246.

Which agency awarded contract FA239625FB246?

Air Force (Department of Defense) awarded FA239625FB246, with funding from Defense Health Agency (Department of Defense).

Is contract FA239625FB246 an order under another contract?

Yes. FA239625FB246 is a BPA call under FA239625AB004, a blanket purchase agreement.

Was contract FA239625FB246 competed?

The extent of competition for FA239625FB246 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award